Physician profile
Michaela Straznicka
NPI 1003858283
$4,741.90
in general payments reported to CMS, 2019-2025
19 companies · $185 in 2025
The $185 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $576 · 2020: $50.93 · 2021: $548 · 2022: $290 · 2023: $2,311 · 2024: $782 · 2025: $185.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $2,385 · Food and Beverage: $893.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $2,385.00 |
| Food and Beverage | $892.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $2,688.92 | 2019-2024 | Imfinzi |
| Medtronic, INC. | $774.59 | 2021-2025 | Illumisite |
| Intuitive Surgical, INC. | $321.88 | 2019-2023 | Da Vinci Surgical System |
| Becton, Dickinson and Company | $153.53 | 2019-2024 | Arista Ah Flexitip |
| Zimmer Biomet Holdings, INC. | $145.00 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $114.62 | 2023 | Opdivo |
| Atricure, INC. | $104.21 | 2021-2025 | Atricure Cryoice Cryosphere Cryoablation System |
| Pulmonx Corporation | $95.07 | 2024-2025 | Zephyr Endobronchial Valve, Zephyr Delivery Catheter, Pulmonx Chartis Tablet Console |
| Davol INC. | $82.97 | 2021 | |
| Covidien LP | $39.96 | 2019 | |
| Pinnacle Biologics, INC | $39.89 | 2021-2022 | |
| Hemosonics LLC | $31.95 | 2020 | |
| Ethicon US, LLC | $28.02 | 2022 | |
| Phathom Pharmaceuticals, INC. | $24.93 | 2025 | Voquezna |
| Siemens Medical Solutions USA, INC. | $22.68 | 2023 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $20.64 | 2024 | Acquire |
| Ethicon INC. | $18.98 | 2020 | |
| Innocoll Pharmaceuticals Limited | $18.15 | 2021 | |
| Emd Serono, INC. | $15.91 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michaela Straznicka listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.